{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T12:31:05Z","timestamp":1780144265530,"version":"3.54.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.vaccine.2024.126462","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T07:22:29Z","timestamp":1729754549000},"page":"126462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Acute autoimmune hepatitis following COVID-19 mRNA vaccination: A population-based study using electronic health records in Singapore"],"prefix":"10.1016","volume":"42","author":[{"given":"Amelia Jing Jing","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desmond Chun Hwee","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreemanee Raaj","family":"Dorajoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron Jun Yi","family":"Yap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Cheng","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas Kai Ming","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally Bee Leng","family":"Soh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2024.126462_bb0005","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jhep.2021.04.003","article-title":"Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty?","volume":"75","author":"Bril","year":"2021","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.vaccine.2024.126462_bb0010","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1007\/s10620-022-07504-w","article-title":"Autoimmune hepatitis-like syndrome following COVID-19 vaccination: a systematic review of the literature","volume":"67","author":"Chow","year":"2022","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126462_bb0015","article-title":"Histological and serological features of acute liver injury after SARS-CoV-2 vaccination","volume":"5","author":"Codoni","year":"2023","journal-title":"JHEP Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2024.126462_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101841","article-title":"Autoimmune hepatitis developing after COVID 19 vaccine: presumed guilty?","volume":"46","author":"Erard","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"5","key":"10.1016\/j.vaccine.2024.126462_bb0025","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/liv.15224","article-title":"Autoimmune hepatitis or drug-induced autoimmune hepatitis following Covid-19 vaccination?","volume":"42","author":"Fimiano","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.vaccine.2024.126462_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102741","article-title":"Autoimmune hepatitis after COVID-19 vaccine \u2013 more than a coincidence","volume":"125","author":"Garrido","year":"2021","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2024.126462_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102706","article-title":"Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: a novel clinical entity?","volume":"123","author":"Ghielmetti","year":"2021","journal-title":"J Autoimmun"},{"issue":"6","key":"10.1016\/j.vaccine.2024.126462_bb0040","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1177\/10668969231177877","article-title":"Clinicopathological characteristics of autoimmune-like hepatitis induced by COVID-19 mRNA vaccine (Pfizer-BioNTech, BNT162b2): a case report and literature review","volume":"31","author":"Kim","year":"2023","journal-title":"Int J Surg Pathol"},{"issue":"5","key":"10.1016\/j.vaccine.2024.126462_bb0045","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jhep.2021.07.005","article-title":"An unusual case of acute cholestatic hepatitis after m-RNABNT162b2 (Comirnaty) SARS-CoV-2 vaccine: coincidence, autoimmunity or drug-related liver injury","volume":"75","author":"Lodato","year":"2021","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.vaccine.2024.126462_bb0050","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.jhep.2021.06.004","article-title":"Another case of autoimmune hepatitis after SARS-CoV-2 vaccination &#x2013; still casualty?","volume":"75","author":"Londo\u00f1o","year":"2021","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.vaccine.2024.126462_bb0055","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.jhep.2021.06.044","article-title":"The mRNA COVID-19 vaccine \u2013 a rare trigger of autoimmune hepatitis?","volume":"75","author":"McShane","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.vaccine.2024.126462_bb0060","first-page":"10","article-title":"Acute hepatitis with autoimmune features after COVID-19 vaccine: coincidence or vaccine-induced phenomenon?","author":"Pinazo-Bandera","year":"2022","journal-title":"Gastroenterology Rep"},{"key":"10.1016\/j.vaccine.2024.126462_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102688","article-title":"Auto-immune hepatitis following COVID vaccination","volume":"123","author":"Rela","year":"2021","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.vaccine.2024.126462_bb0070","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jhep.2021.05.038","article-title":"Autoimmune hepatitis following SARS-CoV-2 vaccine: may not be a casuality","volume":"75","author":"Rocco","year":"2021","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.vaccine.2024.126462_bb0075","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.3390\/vaccines10122073","article-title":"Vaccine-related autoimmune hepatitis: emerging association with SARS-CoV-2 vaccination or coincidence?","volume":"10","author":"Trontzas","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2024.126462_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102710","article-title":"Autoimmune hepatitis triggered by SARS-CoV-2 vaccination","volume":"123","author":"Vuille-Lessard","year":"2021","journal-title":"J Autoimmun"},{"issue":"10","key":"10.1016\/j.vaccine.2024.126462_bb0085","article-title":"COVID-19 vaccination-induced Cholangiopathy and autoimmune hepatitis: a series of two cases","volume":"14","author":"Zafar","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.vaccine.2024.126462_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1035073","article-title":"Autoimmune hepatitis after COVID-19 vaccination","volume":"13","author":"Zheng","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.126462_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/diseases11020080","article-title":"Ye clinical features of COVID-19 vaccine-associated autoimmune hepatitis: a systematic review","volume":"11","author":"Zhou","year":"2023","journal-title":"Diseases"},{"issue":"3","key":"10.1016\/j.vaccine.2024.126462_bb0100","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jhep.2021.09.031","article-title":"Immune-mediated hepatitis with the Moderna vaccine, no longer a coincidence but confirmed","volume":"76","author":"Zin Tun","year":"2022","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.vaccine.2024.126462_bb0105","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"Autoimmune hepatitis","volume":"63","author":"EASL Clinical Practice Guidelines","year":"2015","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.vaccine.2024.126462_bb0110","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s10620-012-2445-4","article-title":"Acute and acute severe (fulminant) autoimmune hepatitis","volume":"58","author":"Czaja","year":"2013","journal-title":"Dig Dis Sci"},{"issue":"16","key":"10.1016\/j.vaccine.2024.126462_bb0115","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.3748\/wjg.v17.i16.2070","article-title":"Optimizing management in autoimmune hepatitis with liver failure at initial presentation","volume":"17","author":"Potts","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.vaccine.2024.126462_bb0120","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jhep.2022.03.040","article-title":"SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis","volume":"77","author":"Boettler","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.vaccine.2024.126462_bb0125","article-title":"Real-world evidence of autoimmune hepatitis following COVID-19 vaccination: a population-based pharmacovigilance analysis","volume":"14","author":"Chen","year":"2023","journal-title":"Front Pharmacol"},{"issue":"10305","key":"10.1016\/j.vaccine.2024.126462_bb0130","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0140-6736(21)00252-X","article-title":"Singapore's health-care system: key features, challenges, and shifts","volume":"398","author":"Tan","year":"2021","journal-title":"The Lancet"},{"issue":"9","key":"10.1016\/j.vaccine.2024.126462_bb0135","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1007\/s10620-017-4675-y","article-title":"Global disparities and their implications in the occurrence and outcome of autoimmune hepatitis","volume":"62","author":"Czaja","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.vaccine.2024.126462_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/6470847","article-title":"Autoimmune hepatitis with acute presentation: clinical, biochemical, and histological features of 126 patients","volume":"2022","author":"Urz\u00faa","year":"2022","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.vaccine.2024.126462_bb0145","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/sim.7536","article-title":"Investigating the assumptions of the self-controlled case series method","volume":"37","author":"Whitaker","year":"2018","journal-title":"Stat Med"},{"issue":"3","key":"10.1016\/j.vaccine.2024.126462_bb0150","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jhep.2023.05.020","article-title":"Morphologic and molecular analysis of liver injury after SARS-CoV-2 vaccination reveals distinct characteristics","volume":"79","author":"Uzun","year":"2023","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.vaccine.2024.126462_bb0155","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/1751-2980.12085","article-title":"Autoimmune hepatitis in southern Israel: a 15-year multicenter study","volume":"14","author":"Delgado","year":"2013","journal-title":"J Dig Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2024.126462_bb0160","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1440-1746.2010.06384.x","article-title":"Population-based epidemiology study of autoimmune hepatitis: a disease of older women?","volume":"25","author":"Ngu","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.vaccine.2024.126462_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182391","article-title":"Population-based prevalence, incidence, and disease burden of autoimmune hepatitis in South Korea","volume":"12","author":"Kim","year":"2017","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.vaccine.2024.126462_bb0170","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/hepr.12639","article-title":"Incidence and prevalence of autoimmune hepatitis in the Ueda area","volume":"46","author":"Yoshizawa","year":"2016","journal-title":"Japan Hepatol Res"},{"issue":"12","key":"10.1016\/j.vaccine.2024.126462_bb0175","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1046\/j.1440-1746.2001.02646.x","article-title":"Autoimmune hepatitis in Singapore: a rare syndrome affecting middle-aged women","volume":"16","author":"Lee","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.vaccine.2024.126462_bb0180","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3109\/00365521.2014.946083","article-title":"Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands","volume":"49","author":"van Gerven","year":"2014","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126462_bb0185","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s12876-022-02507-3","article-title":"New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review","volume":"22","author":"Alhumaid","year":"2022","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"10.1016\/j.vaccine.2024.126462_bb0190","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.aohep.2018.09.001","article-title":"Acute onset autoimmune hepatitis: clinical presentation and treatment outcomes","volume":"18","author":"Aljumah","year":"2019","journal-title":"Ann Hepatol"},{"issue":"7","key":"10.1016\/j.vaccine.2024.126462_bb0195","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/qjmed\/hch072","article-title":"Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the \u2018acute\u2019 type","volume":"97","author":"Ferrari","year":"2004","journal-title":"QJM: Int J Med"},{"key":"10.1016\/j.vaccine.2024.126462_bb0200","article-title":"Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: an analysis of national surveillance data during week 1-2016 - week 32-2020","volume":"6","author":"Ullrich","year":"2021","journal-title":"Lancet Reg Health Eur"},{"issue":"3","key":"10.1016\/j.vaccine.2024.126462_bb0205","volume":"11","year":"2021","journal-title":"BMJ Open"},{"issue":"11","key":"10.1016\/j.vaccine.2024.126462_bb0210","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/0141076820962447","article-title":"Impact of COVID-19 on accident and emergency attendances and emergency and planned hospital admissions in Scotland: an interrupted time-series analysis","volume":"113","author":"Mulholland","year":"2020","journal-title":"J R Soc Med"},{"key":"10.1016\/j.vaccine.2024.126462_bb0215","doi-asserted-by":"crossref","DOI":"10.2196\/48159","article-title":"Impact of the COVID-19 pandemic on health care utilization in the vaccine safety datalink: retrospective cohort study","volume":"10","author":"Qian","year":"2024","journal-title":"JMIR Public Health Surveill"},{"key":"10.1016\/j.vaccine.2024.126462_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108480","article-title":"Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases","volume":"217","author":"Vojdani","year":"2020","journal-title":"Clin Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2024.126462_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103287","article-title":"Autoimmune\/inflammatory syndrome induced by adjuvants (ASIA) in 2023","volume":"22","author":"Cohen Tervaert","year":"2023","journal-title":"Autoimmun Rev"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24011447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24011447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T17:44:01Z","timestamp":1741887841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24011447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":45,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0264410X24011447"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126462","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute autoimmune hepatitis following COVID-19 mRNA vaccination: A population-based study using electronic health records in Singapore","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126462","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126462"}}